Acute kidney injury after CAR-T cell infusion
Authors:
- 8 October 2022
- journal article
- review article
- Published by Elsevier in Bulletin du Cancer
- Vol. 111 (7-8) , 748-753
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen ReceptorJournal of Clinical Oncology, 2015
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialThe Lancet, 2015
- Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaNew England Journal of Medicine, 2014
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- The pathogenesis and diagnosis of acute kidney injury in multiple myelomaNature Reviews Nephrology, 2011
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high‐risk myelodysplastic syndromeCancer, 2010
- Cyclophosphamide-associated complications: we need to be aware of SIADH and central pontine myelinolysisRheumatology, 2008
- Nephrotic syndrome associated with hemophagocytic syndromeKidney International, 2006
- A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndromePediatric Nephrology, 2006